Latest AI and machine learning research in chemotherapy for healthcare professionals.
Osteosarcoma (OS) is an aggressive primary bone malignancy. Accurate histopathological assessment of...
Currently, chemotherapy drugs are the first-line treatment for lung cancer patients, and evaluating ...
BACKGROUND: Triple negative breast cancer (TNBC) is an aggressive subcategory of breast cancer with ...
Osteosarcoma (OS) is an aggressive bone cancer that mainly occurs in children and adolescents. OS pa...
UNLABELLED: Accurate preoperative assessment of lymph node metastasis (LNM) and overall survival (OS...
UNLABELLED: Breast and ovarian cancers harboring homologous recombination deficiency (HRD) are sensi...
Homologous recombination is a high-fidelity DNA repair mechanism essential for maintaining genome st...
Ovarian cancer remains the third most prevalent and deadliest gynecologic malignancy worldwide, with...
PURPOSE: Noninvasive, accurate and novel approaches to predict patients who will achieve pathologica...
This study presents a comprehensive machine learning-driven analysis to understand and predict the t...
Tumor-infiltrating lymphocytes (TILs) are capable of recognizing tumor antigens, impacting tumor pro...
BACKGROUND AND AIMS: Osteosarcoma (OS) is the most common primary bone malignancy, and neoadjuvant c...
Neoadjuvant chemoradiotherapy (NACRT) is the standard treatment for locally advanced rectal cancer (...
Epithelial ovarian cancer remains one of the deadliest gynecologic malignancies, with late-stage dia...
PURPOSE: This study aimed to develop a machine learning (ML) model to predict bloodstream infection ...
Androgenetic alopecia (AGA), the most common form of hair loss, has been linked to dysbiosis of the ...
PURPOSE: Although the association between cytotoxic T lymphocytes and favorable prognosis in colorec...
Gallbladder cancer has an insidious onset,and most of the cases are in advanced stage at the time of...
Cancer pain management (CPM) is crucial in oncology care, with current approaches including pharmaco...
The clinical benefits of neoadjuvant chemoimmunotherapy (NACI) are demonstrated in patients with bla...
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) have reshaped the treatment paradigm of hormone rec...